Responses
Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
499 The small molecule PD-L1 inhibitor CCX559 preferentially accumulates in tumors, resulting in depletion of cell-surface PD-L1 in a murine preclinical model
Compose a Response to This Article
Other responses
No responses have been published for this article.